Elsevier, Bioorganic and Medicinal Chemistry Letters, 14(18), p. 4210-4214
DOI: 10.1016/j.bmcl.2008.05.068
Full text: Unavailable
The structure-based design, chemical synthesis and in vitro activity evaluation of various falcipain inhibitors derived from 2-pyridone are reported. These compounds contain a peptidomimetic binding determinant and a Michael acceptor terminal moiety capable of deactivating the cysteine protease active site. (C) 2008 Elsevier Ltd. All rights reserved.